Ying Huang Qian Wang Silin Zeng Yaqing Zhang Liangyu Zou Xuejun Fu Qianhui Xu
10.3389/fimmu.2020.595417
Front Immunol
2020 Dec 9;11:595417.
anti-nmda antibody anti-nmda receptor encephalitis atypical symptoms multiple sclerosis overlap
CC BY
https://pubmed.ncbi.nlm.nih.gov/33362777/
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / diagnosis Multiple Sclerosis, Relapsing-Remitting / diagnosis
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / diagnosis Multiple Sclerosis, Relapsing-Remitting / diagnosis Case Reports Review Adult Anti-Inflammatory Agents / therapeutic use Anti-N-Methyl-D-Aspartate Receptor Encephalitis / drug therapy Anticonvulsants / therapeutic use Antipsychotic Agents / therapeutic use Female Humans Immunoglobulins, Intravenous / therapeutic use Immunologic Factors / therapeutic use Levetiracetam / therapeutic use Methylprednisolone / therapeutic use Multiple Sclerosis, Relapsing-Remitting / drug therapy Olanzapine / therapeutic use Prednisolone / therapeutic use Anti-Inflammatory Agents Anticonvulsants Antipsychotic Agents Immunoglobulins, Intravenous Immunologic Factors Levetiracetam Prednisolone Olanzapine Methylprednisolone
PMC7756053
33362777
Case Report: Overlapping Multiple Sclerosis With Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report and Review of Literature
2020